Newby DE - Search Results

1

Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology.

Dweck MR, Chow MW, Joshi NV, Williams MC, Jones C, Fletcher AM, Richardson H, White A, McKillop G, van Beek EJ, Boon NA, Rudd JH, Newby DE. Dweck MR, et al. Among authors: newby de. J Am Coll Cardiol. 2012 Apr 24;59(17):1539-48. doi: 10.1016/j.jacc.2011.12.037. J Am Coll Cardiol. 2012. PMID: 22516444 Free article. Clinical Trial.

2

Caffeine restriction has no role in the management of patients with symptomatic idiopathic ventricular premature beats.

Newby DE, Neilson JM, Jarvie DR, Boon NA. Newby DE, et al. Heart. 1996 Oct;76(4):355-7. doi: 10.1136/hrt.76.4.355. Heart. 1996. PMID: 8983684 Free PMC article. Clinical Trial.

3

Comparison of forearm vasodilatation to substance P and acetylcholine: contribution of nitric oxide.

Newby DE, Boon NA, Webb DJ. Newby DE, et al. Clin Sci (Lond). 1997 Feb;92(2):133-8. doi: 10.1042/cs0920133. Clin Sci (Lond). 1997. PMID: 9059313 Clinical Trial.

4

Intra-arterial substance P mediated vasodilatation in the human forearm: pharmacology, reproducibility and tolerability.

Newby DE, Sciberras DG, Mendel CM, Gertz BJ, Boon NA, Webb DJ. Newby DE, et al. Br J Clin Pharmacol. 1997 May;43(5):493-9. doi: 10.1046/j.1365-2125.1997.00583.x. Br J Clin Pharmacol. 1997. PMID: 9159564 Free PMC article. Clinical Trial.

5

Endogenous angiotensin II does not contribute to sympathetic venoconstriction in dorsal hand veins of healthy humans.

Masumori S, Newby DE, Strachan FE, Boon NA, Webb DJ. Masumori S, et al. Among authors: newby de. Clin Pharmacol Ther. 1997 Sep;62(3):327-33. doi: 10.1016/S0009-9236(97)90036-9. Clin Pharmacol Ther. 1997. PMID: 9333109 Clinical Trial.

6

An in vivo model for the assessment of acute fibrinolytic capacity of the endothelium.

Newby DE, Wright RA, Ludlam CA, Fox KA, Boon NA, Webb DJ. Newby DE, et al. Thromb Haemost. 1997 Oct;78(4):1242-8. Thromb Haemost. 1997. PMID: 9364992

7

Endogenous angiotensin II contributes to basal peripheral vascular tone in sodium deplete but not sodium replete man.

Newby DE, Masumori S, Johnston NR, Boon NA, Webb DJ. Newby DE, et al. Cardiovasc Res. 1997 Nov;36(2):268-75. doi: 10.1016/s0008-6363(97)00171-5. Cardiovasc Res. 1997. PMID: 9463638 Clinical Trial.

8

Reduced responsiveness to endothelin-1 in peripheral resistance vessels of patients with syndrome X.

Newby DE, Flint LL, Fox KA, Boon NA, Webb DJ. Newby DE, et al. J Am Coll Cardiol. 1998 Jun;31(7):1585-90. doi: 10.1016/s0735-1097(98)00143-0. J Am Coll Cardiol. 1998. PMID: 9626838 Free article. Clinical Trial.

9

Peripheral vascular tone in patients with cirrhosis: role of the renin-angiotensin and sympathetic nervous systems.

Newby DE, Jalan R, Masumori S, Hayes PC, Boon NA, Webb DJ. Newby DE, et al. Cardiovasc Res. 1998 Apr;38(1):221-8. doi: 10.1016/s0008-6363(98)00008-x. Cardiovasc Res. 1998. PMID: 9683925

10

The L-arginine/nitric oxide pathway contributes to the acute release of tissue plasminogen activator in vivo in man.

Newby DE, Wright RA, Dawson P, Ludlam CA, Boon NA, Fox KA, Webb DJ. Newby DE, et al. Cardiovasc Res. 1998 May;38(2):485-92. doi: 10.1016/s0008-6363(98)00017-0. Cardiovasc Res. 1998. PMID: 9709410 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

867 results

Search Page

Filters